Infections in biological and targeted synthetic drug use in rheumatoid arthritis: where do we stand? A scoping review and meta-analysis
View ORCID ProfileBJM Bergmans, BY Gebeyehu, EP van Puijenbroek, K Van Deun, B Kleinberg, View ORCID ProfileJL Murk, E de Vries
doi: https://doi.org/10.1101/2023.03.09.23287022
BJM Bergmans
1Tranzo, Tilburg School of Social and Behavioral Sciences, Tilburg University, Tilburg, The Netherlands
2Department of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands
BY Gebeyehu
1Tranzo, Tilburg School of Social and Behavioral Sciences, Tilburg University, Tilburg, The Netherlands
3Department of Methodology and Statistics, Tilburg School of Social and Behavioral Sciences, Tilburg University, Tilburg, The Netherlands
EP van Puijenbroek
4Netherlands Pharmacovigilance Centre Lareb, ‘s-Hertogenbosch, The Netherlands
5University of Groningen, Groningen Research Institute of Pharmacy, PharmacoTherapy, - Epidemiology & -Economics, Groningen, The Netherlands
K Van Deun
3Department of Methodology and Statistics, Tilburg School of Social and Behavioral Sciences, Tilburg University, Tilburg, The Netherlands
B Kleinberg
3Department of Methodology and Statistics, Tilburg School of Social and Behavioral Sciences, Tilburg University, Tilburg, The Netherlands
JL Murk
2Department of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands
6Microvida, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands
E de Vries
1Tranzo, Tilburg School of Social and Behavioral Sciences, Tilburg University, Tilburg, The Netherlands
2Department of Medical Microbiology and Immunology, Elisabeth-TweeSteden Hospital, Tilburg, The Netherlands

- Supplementary appendix[supplements/287022_file05.docx]
- Appendix 3[supplements/287022_file06.xlsx]
- Appendix 4[supplements/287022_file07.xlsx]
- PRISMA checklist[supplements/287022_file08.docx]
Posted March 09, 2023.
Infections in biological and targeted synthetic drug use in rheumatoid arthritis: where do we stand? A scoping review and meta-analysis
BJM Bergmans, BY Gebeyehu, EP van Puijenbroek, K Van Deun, B Kleinberg, JL Murk, E de Vries
medRxiv 2023.03.09.23287022; doi: https://doi.org/10.1101/2023.03.09.23287022
Infections in biological and targeted synthetic drug use in rheumatoid arthritis: where do we stand? A scoping review and meta-analysis
BJM Bergmans, BY Gebeyehu, EP van Puijenbroek, K Van Deun, B Kleinberg, JL Murk, E de Vries
medRxiv 2023.03.09.23287022; doi: https://doi.org/10.1101/2023.03.09.23287022
Subject Area
Subject Areas
- Addiction Medicine (349)
- Allergy and Immunology (668)
- Allergy and Immunology (668)
- Anesthesia (181)
- Cardiovascular Medicine (2648)
- Dermatology (223)
- Emergency Medicine (399)
- Epidemiology (12228)
- Forensic Medicine (10)
- Gastroenterology (759)
- Genetic and Genomic Medicine (4103)
- Geriatric Medicine (387)
- Health Economics (680)
- Health Informatics (2657)
- Health Policy (1005)
- Hematology (363)
- HIV/AIDS (851)
- Medical Education (399)
- Medical Ethics (109)
- Nephrology (436)
- Neurology (3882)
- Nursing (209)
- Nutrition (577)
- Oncology (2030)
- Ophthalmology (585)
- Orthopedics (240)
- Otolaryngology (306)
- Pain Medicine (250)
- Palliative Medicine (75)
- Pathology (473)
- Pediatrics (1115)
- Primary Care Research (452)
- Public and Global Health (6527)
- Radiology and Imaging (1403)
- Respiratory Medicine (871)
- Rheumatology (409)
- Sports Medicine (342)
- Surgery (448)
- Toxicology (53)
- Transplantation (185)
- Urology (165)